Singapore
Wen Ken Group, founded in 1937, stands out as a prominent player in the pharmaceutical sector in Singapore and Malaysia, with an expansive reach into international markets. The company's slogan, "Providing affordable healthcare for the benefit of all," reflects its commitment to accessible medical solutions.
Specializing in Traditional Chinese Medicine (TCM), over-the-counter (OTC) products, and health supplements, Wen Ken Group prioritizes innovation underpinned by a robust R&D model. Professors Zhu Wen Jun and Mr Young Siew Wah lead the research team, each boasting over 30 years of expertise in TCM advancement. Meanwhile, modern facilities ensure product safety, quality, and efficacy.
In addition to its consumer products, the company offers holistic contract manufacturing services (OEM), enhancing its value proposition. Its industry leadership positions it as a potential interest for investors seeking established companies with a strong legacy and continuous innovation.
